Using human A-Fib simulations, the researchers have demonstrated that their...
Using human A-Fib simulations, the researchers have demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate. This new algorithm also is effective in scarred tissue, which makes ablation more challenging, and has a 99 percent detection rate regardless of the scar size.
Source: Florida Atlantic University

Algorithm steers catheters to the right spot to treat atrial fibrillation

Researchers have demonstrated that their technique can stop the catheter at the right target and identify the source type with a 95.25 percent success rate.

Patients with atrial fibrillation or AFib experience chaotic electrical signals in the upper chamber of their heart (atria), which cause an irregular or quivering heartbeat (arrhythmia) that can lead to blood clots and heart failure. AFib also is a major cause of stroke and affects 33 million people worldwide.

When medications and other treatments fail, specially trained cardiologists (electrophysiologists) turn to ablation, which involves a catheter that is gently guided to the heart to destroy malfunctioning tissue and scar the problematic areas. Prior to surgery, electrophysiologists require advanced 3D mapping of the heart to direct them to problematic areas, which is a laborious and time-consuming process.

This procedure also poses a number of challenges for physicians including low, long-term success rates, which requires a need for new techniques to successfully guide catheter movements and accurately detect AFib targets.

Researchers from Florida Atlantic University’s College of Engineering and Computer Science and collaborators have developed the first algorithm that can locate patient-specific ablation targets within the atria that does not require specialized catheters or 3D electro-anatomic maps of the heart. The new algorithm – the iterative catheter navigation (ICAN) – is fundamentally different from existing approaches.

In the study, the researchers demonstrate that ICAN stops the catheter when it finds the AFib source and identifies the source type with a success rate of more than 95.25 percent using human AFib simulations. Researchers also tested the effectiveness of ICAN in the presence of fibrosis and patchy myocardial scars, which makes AFib source detection more challenging, with a 99 percent detection rate regardless of the scar size, using human AFib simulations.

ICAN iteratively navigates a catheter toward AFib sources, does not involve electrophysiological mapping of the entire surface of the heart, and does not make any assumptions on the AFib source types to navigate the catheter. As a result, this algorithm can be used for locating different types of AFib sources such as rotational circuits and focal beats. “We have developed the first algorithm to localize atrial fibrillation sources by iteratively navigating a 20-electrode circular catheter that is routinely used for ablation procedures,” said Behnaz Ghoraani, Ph.D., senior author, an assistant professor in FAU’s Department of Computer and Electrical Engineering and Computer Science, and a fellow of FAU’s Institute for Sensing and Embedded Network Systems (I-SENSE) and FAU’s Brain Institute (I-BRAIN), two of the university’s four research pillars. “ICAN guides the incremental movements of this catheter from an arbitrary initial placement on the atrial tissue until a source of arrhythmia, rotor or focal, is detected by the algorithm.”

Ghoraani and collaborators from the Rochester Institute of Technology, the University of Rochester Medical Center, and SUNY Upstate Medical Center, tested ICAN on realistic simulated data with several test cases of rotor and foci-driven arrhythmias, which covered a broad range of activation patterns in 2D as well as 3D AFib simulations. They placed the catheter on 114,921 initial catheter locations across the simulated region for different rotor and foci mechanisms. In all cases, they modeled globally distributed fibrosis.

“Professor Ghoraani and her collaborators have developed a cutting-edge technique that has the potential to be a game-changer in how electrophysiologists treat atrial fibrillation with ablation,” said Stella Batalama, Ph.D., dean of FAU’s College of Engineering and Computer Science. “The high performance of this algorithm is evident by the high source detection success rate. ICAN could significantly improve the success of patient-specific atrial fibrillation ablation and facilitate treating patients before the disease progresses to the permanent stage.”

In addition, the researchers have demonstrated the feasibility of their study in a few human clinical AFib cases and plan to further validate ICAN in more patients. There are currently two patents pending for certain aspects of the algorithm.

Subscribe to our newsletter

Related articles

Cardivascular diseases: digital twin improves therapy

Cardivascular diseases: digital twin improves therapy

Using mathematical image processing, scientists have found a way to create digital twins from human hearts.

Wearable heart monitor detects of atrial fibrillation early

Wearable heart monitor detects of atrial fibrillation early

A small, wearable heart monitor can detect atrial fibrillation in high-risk patients ten times more frequently than standard tests.

AI makes strides in search for COVID-19 treatments

AI makes strides in search for COVID-19 treatments

A deep learning model that can predict how human genes and medicines will interact has identified at least 10 compounds that may hold promise as treatments for COVID-19.

Wearable ultrasound: nonsurgical treatment for cerebral infarction

Wearable ultrasound: nonsurgical treatment for cerebral infarction

Preclinical efficacy validation of a light-weight wearable wireless ultrasound brain stimulator for stroke rehabilitation.

Exoskeleton and brain-machine interface boost stroke rehab

Exoskeleton and brain-machine interface boost stroke rehab

Researchers have developed a system that combines a brain-computer interface and a robotic arm that responds to the actual intentions of treated patients.

VR applied to rehabilitation for stroke patients

VR applied to rehabilitation for stroke patients

VR-based rehabilitation programs are becoming an important complement to conventional motor therapy for stroke patients and individuals with neurodegenerative diseases.

Bioprinted heart provides new tool for surgeons

Bioprinted heart provides new tool for surgeons

Surgeons will soon have a powerful new tool for planning and practice with the creation of the first full-sized 3D bioprinted model of the human heart.

Cardiac patch treats heart disease

Cardiac patch treats heart disease

Researchers have developed rubbery a bioelectronic implantable device that can monitor and treat heart diseases.

A portable arm rehabilitation robot

A portable arm rehabilitation robot

A new portable arm rehabilitation robot will help patients to carry out robot-aided therapy at home, allowing them to perform intensive exercises without visiting hospitals or clinics.

Popular articles